Company News
15
06. 2020
New LTS Web seminar
LTS will host a web seminar titled ‘LTS Oral Thin Film Technology – Adaptable like a Chameleon’ on 29 June.
17
02. 2020
LTS provides new insights
On 17.02. LTS has installed its first digital information display in Lohmannstraße, directly in front of the LTS gate.
16
12. 2019
LTS announces the appointment of David Doles as new President and Chief Executive Officer for its US affiliate LTS Corp.
LTS Lohmann Therapie-Systeme AG, the market leader for the development and manufacturing of transdermal therapeutic systems, is very pleased to announce the appointment of Mr. David Doles as the President and Chief Executive Officer for its US affiliate, LTS Lohmann Therapy Systems, Corp. effective 1 January 2020.
25
10. 2019
European patent granted for LTS’ asenapine TTS
An European Patent for LTS’ application relating to an asenapine transdermal therapeutic system (TTS).
21
02. 2019
Dr. Reddy’s re-launches generic of Buprenorphine and Naloxone Sublingual Film
LTS congratulates its business partner Dr. Reddy’s Laboratories Ltd. for the US launch of its Buprenorphine and Naloxone Sublingual Film.